Today, studies estimate that over 80 percent of the personalized compounded GLP-1 drugs now being marketed include added ingredients such as B vitamins (B6, B12, B3)
MATERIALS AND METHODS The current study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension statement for the reporting of systematic reviews incorporating NMAs of Health Care Interventions (Supplementary Material 10) [28]
Liang X, Fu Y, Cao W-t, Wang Z, Zhang K, Jiang Z, et al
This article covers the receptor binding profiles that differentiate these compounds, the practical implications for dosing and side effect management in research contexts, and the specific applications where one peptide demonstrably outperforms the other